Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

7 treatments under study, led by Collagenase Ointment

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 90/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
Phase 1 (1)
Phase 4 (1)

Trial Status

Terminated1
Unknown1
Completed1
Withdrawn1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT05464407Not ApplicableTerminatedPrimary

High Protein Oral Nutritional Support With Special Nutrients in Patients With Type 2 Diabetes and Foot Ulcer

NCT03211910Not ApplicableWithdrawnPrimary

Sacral Savers: Study of Prevention and Enhanced Healing of Sacral and Trochenteric Ulcers

NCT04963829Phase 1Completed

Unripe Banana Peel Powder and Lemongrass Oil in Chronic Ulcer

NCT01308177Phase 4Unknown

Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection

Showing all 4 trials

Research Network

Common Treatments

  • Collagenase Ointment1
  • Ecabet1
  • Gel Combined With Lemongrass Cymbopogon Citratus Oil At 01 Concentration1
  • Gel With 10 Peel Powder Of Unripe Banana1
  • Cubitan1

Active Sponsors

  • Richmond University Medical Center1
  • Samsung Medical Center1
  • Universidade do Vale do Sapucai1
  • Aalborg University Hospital1

Top Investigators

Related Conditions

  • Chronic Ulcer1
  • Delayed Bleeding1
  • Quality Of Ulcer1

Activity Timeline